Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus-infected patients with decompensated liver disease

Lawitz EJ, Poordad F, Gutierrez JA, et al. Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus-infected patients with decompensated liver disease. J Viral Hepat. 2016 Nov 23th ed. 2017;24(4):287-294.

Publication Type:

Journal Article

Authors:

E J Lawitz; Fred Poordad; Gutierrez, JA.; et, al

Source:

J Viral Hepat, Volume 24, Issue 4, p.287-294 (2017)

Notes:

PMID: 27878906

Cited On:

External Third-party Web Link:

https://www.ncbi.nlm.nih.gov/pubmed/27878906

Export Citation:
RIS Format
Top